MENU
+Compare
KALV
Stock ticker: NASDAQ
AS OF
Aug 25, 01:29 PM (EDT)
Price
$13.54
Change
+$0.14 (+1.04%)
Capitalization
675.06M

KALV KalVista Pharmaceuticals Forecast, Technical & Fundamental Analysis

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs... Show more

KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KALV with price predictions
Aug 22, 2025

KALV's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for KALV moved out of oversold territory on August 13, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where KALV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 20, 2025. You may want to consider a long position or call options on KALV as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KALV just turned positive on August 21, 2025. Looking at past instances where KALV's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KALV advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

KALV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

KALV moved below its 50-day moving average on August 01, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KALV crossed bearishly below the 50-day moving average on August 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KALV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KALV entered a downward trend on August 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KALV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.077) is normal, around the industry mean (19.116). P/E Ratio (0.000) is within average values for comparable stocks, (55.025). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.643). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (305.051).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KALV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

KALV is expected to report earnings to fall 3.17% to -95 cents per share on September 04

KalVista Pharmaceuticals KALV Stock Earnings Reports
Q3'25
Est.
$-0.96
Q2'25
Missed
by $0.14
Q1'25
Missed
by $0.05
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.03
The last earnings report on July 10 showed earnings per share of -99 cents, missing the estimate of -84 cents. With 68.93K shares outstanding, the current market capitalization sits at 675.06M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMIX26.010.47
+1.84%
Macquarie Emerging Markets Instl
AILLX28.520.46
+1.64%
Aristotle Core Equity I-2
BGPKX13.790.22
+1.62%
Baillie Gifford Developed EAFE All Cap K
POSAX9.060.12
+1.34%
Principal Global Real Estate Sec A
AFPIX4.50N/A
N/A
DSS AmericaFirst Income I

KALV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with ATXS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
+3.47%
ATXS - KALV
45%
Loosely correlated
+6.93%
COGT - KALV
42%
Loosely correlated
+2.97%
IDYA - KALV
40%
Loosely correlated
+1.99%
IRON - KALV
40%
Loosely correlated
+1.00%
ETNB - KALV
40%
Loosely correlated
+2.61%
More